ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Clinical Research by Anderson Biotests, LLC, in Collaboration With the Bedford Research Foundation, Suggests New Paradigm for Determining Vasectomy Success

Massachusetts laboratory scientists conducting semen research develop unique home collection kit for sperm count following vasectomy

PVSA
PVSA

Logo of PVSA

Anderson Biotests, LLC, in collaboration with the Bedford Research Foundation (www.bedfordresearch.org), recently published results of analyses of 5,408 post-vasectomy semen specimens (https://doi.org/10.1111/andr.13331) that reveal there is no need for at least 95% of men undergoing vasectomy to return a fresh semen specimen to a laboratory or the doctor's office for a sperm count within two hours of collection. The vasectomy is considered a success in both Canada and the U.S. if fewer than 100,000 motile sperm are present in a semen specimen collected a few weeks after the surgery and examined within two hours of collection. This requirement is thought to account for the poor compliance (about 43% of patients) with post-vasectomy semen analyses. The basic finding in the new report is that the vast majority of semen specimens a few weeks after vasectomy have so few sperm (fewer than 11,000) that motility assessment is irrelevant. This reported finding is a significant clinical advance, in addition to the ease of producing a semen specimen at home and mailing it to a clinically certified laboratory for sperm count.     

This advance is especially timely given the marked uptick in requests for vasectomy procedures by men in the U.S. following the Supreme Court overturn of Roe v Wade. Although vasectomy is a more successful sterility procedure than tubal ligation of women, vasectomy has been employed by fewer than 10% of couples seeking non-hormonal birth control. Many family planning experts have encouraged a wider use of vasectomy, a simple, rapid, safe surgical procedure followed by minimal discomfort and no change in sexual activity.  

The home collection kit itself is manufactured by Anderson Biotest and features a patented preservative that stabilizes the semen specimen for transport back to the lab for sperm count. Kit cost of $45 includes sperm count and report. Submission of two kits to fully verify the absence of sperm is recommended by physicians and professional societies. For more information, visit www.pvsa.org.

Contact Information:
Alexander Hauser
Lead Technician
alex@bedfordresearch.org
617-623-7447

Ryan Kiessling
Director of Operations
ryan@bedfordresearch.org
6172817902
Related Files
Andrology - 2022 - Kiessling - A new approach to postvasectomy semen analyses eliminates the need to evaluate a fresh.pdf



Original Source: Clinical Research by Anderson Biotests, LLC, in Collaboration With the Bedford Research Foundation, Suggests New Paradigm for Determining Vasectomy Success
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.